Effects of combined enalapril and folic acid therapy on the serum uric acid levels in hypertensive patients: a multicenter, randomized, double-blind, parallel-controlled clinical trial

Internal Medicine
Haibo LiXiping Xu

Abstract

Objective The efficacy of combined treatment consisting of enalapril and folic acid (FA) was compared to that of enalapril alone in reducing the serum uric acid (UA) levels in adult hypertensive patients in China. Methods Patients with mild to moderate hypertension (n=480) were randomly assigned to one of three treatment groups: (1) 10 mg enalapril (control group), (2) 10 mg enalapril plus 0.4 mg FA (low-FA group) or (3) 10 mg enalapril plus 0.8 mg FA (high-FA group) daily for eight weeks. The primary outcome was the UA ratio (week 8 UA: baseline UA). Results The final analysis included 450 patients (43.1% men, 27-75 years of age). An adjusted multivariable regression analysis revealed no significant differences in the UA ratio between the three groups after eight weeks of treatment. In the subgroup analysis stratified according to the baseline UA level, the high-FA group demonstrated a significantly greater UA-lowering response among the patients with an elevated baseline UA concentration (UA ≥310 μmol/L) [median UA ratio (25th percentile, 75th percentile): 0.94 (0.83, 1.01)], compared with that observed in the control group [0.97 (0.90, 1.00), p=0.025]. Similar results were found in the participants with baseline hyperuricemi...Continue Reading

References

Mar 1, 1977·Annals of Internal Medicine·K A Oster
May 3, 2000·American Journal of Epidemiology·L D Botto, Q Yang
Oct 3, 2003·The American Journal of Clinical Nutrition·Li-Ching LyuChing-Lan Chen
Dec 1, 1950·The American Journal of Medicine
Apr 27, 2004·Cardiovascular Drugs and Therapy·Ariel J Reyes
Jan 20, 2005·JAMA : the Journal of the American Medical Association·John P FormanGary C Curhan
Mar 24, 2005·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Htay LwinHeizo Tanaka
Oct 24, 2008·The New England Journal of Medicine·Daniel I FeigRichard J Johnson
Apr 3, 2009·Current Opinion in Rheumatology·N Lawrence Edwards
Jul 1, 2009·Arthritis and Rheumatism·Seo Young KimDaniel A Albert
Mar 2, 2010·Arthritis Care & Research·Seo Young KimDaniel A Albert
Aug 20, 2010·Lancet·Christopher M Burns, Robert L Wortmann
Sep 9, 2010·Arthritis Care & Research·Peter C GraysonHyon K Choi
Jan 1, 1995·European Journal of Medicinal Chemistry·A KumarRf Schinazi
Feb 2, 2013·Current Opinion in Rheumatology·Terence J Gibson

❮ Previous
Next ❯

Citations

Apr 11, 2017·International Journal of Cancer. Journal International Du Cancer·Juan YangXiping Xu
Jan 31, 2018·The American Journal of Clinical Nutrition·Xianhui QinFan Fan Hou
Aug 18, 2017·The Cochrane Database of Systematic Reviews·Arturo J Martí-CarvajalMark Dayer
Jun 28, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Yin Ting CheungKevin R Krull

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.